Drug
Bromfenac clinical trials
Also written Yellox, Xibrom and ISV-303.
- studies test it
- 45
- open now
- 2
- in phase 3
- 13
- first study started
- 2003
Keep track of what changes. Save the bromfenac studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Combined with it in one product
Studies by the year they started
45 studies that test it; most in 2008 (8)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2006 | 2 |
| 2007 | 5 |
| 2008 | 8 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 4 |
| 2023 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 6
- Phase 3
- 13
- Phase 4
- 22
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
- Cataract
- 24
Who runs them
Industry 15 · Other 30
Bausch & Lomb Incorporated (9) · Bp Consulting, Inc (5) · Sun Pharmaceutical Industries Limited (4) · Azienda USL Reggio Emilia - IRCCS (2) · Frank A. Bucci, Jr., M.D. (2) · Pomeranian Medical University Szczecin (1) · Retina Research Institute, LLC (1) · Inas Abd (1)
Often tested with
Tested in the same studies.
Nepafenac (8) · Ketorolac (7) · Dexamethasone (4) · Ketorolac Tromethamine (4) · Diclofenac (3) · Triamcinolone Acetonide (2) · Loteprednol Etabonate (1) · Bevacizumab (1)
Studies
Open first, then newest update. How each study uses bromfenac is read from its arms, and is right about nine times in ten.
Testing it · 45
- Comparing Efficacy of Bromfenac 0.09%, Nepafenac 0.3% and Diclofenac 0.1% in Patients After Cataract SurgeryRecruitingNot applicableNemocnice KolínNCT07178639Written as Bromfenac 0.09 % Ophthalmic Solution
- Bromfenac Sodium Hydrate Eye Drops in Familial Exudative VitreoretinopathyRecruitingPhase 2Seoul National University HospitalNCT05107921Written as Bromfenac Sodium
- Efficacy of Nonsteroidal Anti-Inflammatory Drugs for the Prevention of Cystoid Macular Edema Following Cataract PhacoemulsificationCompletedPhase 4Pomeranian Medical University SzczecinNCT07696104Written as Bromfenac 0.09 % Ophthalmic Solution
- Comparing Post-intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-hour PeriodCompletedPhase 4Retina Research Institute, LLCNCT07090044Written as Bromfenac Sodium 0.07%
- Bromfenac Versus Dexamethasone After Cataract SurgeryCompletedPhase 4Azienda USL Reggio Emilia - IRCCSNCT03317847Written as Bromfenac 0.09 % Ophthalmic Solution
- Bromfenac to Reduce Inflammation in Patients With Pseudoexfoliation Syndrome After Cataract SurgeryCompletedPhase 4Azienda USL Reggio Emilia - IRCCSNCT02137161Written as Bromfenac eye drop
- Effects of Bromfenac on Macular Thickness After Phacoemulsification SurgeryCompletedPhase 4Inas AbdNCT06785090Written as Bromfenac
- Effectiveness of Periocular Drug Injection in CATaract SurgeryTerminatedPhase 3Luigi RondasNCT05158699Written as Bromfenac
- Control of Pain in Intravitreal Injections Using Topical NSAIDsCompletedPhase 4University of Wisconsin, MadisonNCT04343222Written as Bromfenac
- PCME Prevention in Patients With NPDRCompletedPhase 4Klinički Bolnički Centar ZagrebNCT04940338Written as Bromfenac Ophthalmic 0.09% Ophthalmic Solution
- Comparison Study of ISV-303 to DuraSite Vehicle in Cataract Surgery SubjectsCompletedPhase 3Sun Pharmaceutical Industries LimitedNCT01576952Written as ISV-303
- Study to Compare Differing Dosing Regimens of ISV-303 (Bromfenac in DuraSite) to Xibrom and Vehicle in Post Cataract Surgery VolunteersCompletedPhase 1/2Sun Pharmaceutical Industries LimitedNCT01190878Written as ISV-303
- Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery SubjectsCompletedPhase 3Sun Pharmaceutical Industries LimitedNCT01808547Written as ISV-303
- Aqueous Humor Concentration of InSite Vision (ISV) 303 (Bromfenac in DuraSite) to Bromday Once Daily (QD) Prior to Cataract SurgeryCompletedPhase 2Sun Pharmaceutical Industries LimitedNCT01387464Written as ISV-303
- Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1%CompletedPhase 4Toyos ClinicNCT01310127Written as Bromfenac
- NSAID vs Steroid in Trabeculectomy Wound ManagementStatus unknownPhase 4Cindy HutnikNCT03751059Written as Bromfenac 0.07% Oph Susp
- Safety and Efficacy of an Ophthalmic Solution in Dry Eye DiseaseCompletedPhase 2Bausch & Lomb IncorporatedNCT00758784Written as bromfenac ophthalmic solution 0.06%
- Safety and Tolerability of PRO-155 Ophthalmic Solution 0.09% in Healthy Volunteers.CompletedPhase 1Laboratorios Sophia S.A de C.V.NCT01535443Written as Bromfenac
- Effect of Bromfenac on Pain Related to Pterygium SurgeryCompletedPhase 4Zhongshan Ophthalmic Center, Sun Yat-sen UniversityNCT04022811Written as 0.1% bromfenac
- Study Title: Clinical Outcomes of Prolensa (Bromfenac Ophthalmic Solution) 0.07% QD vs. Ilevro (Nepafenac Ophthalmic Suspension) 0.3% QD With Extra (Pulse) Dose on Day of Surgery for Treatment of Ocular Inflammation Associated With Cataract Surgery in a Randomized, Single Masked Clinical TrialCompletedPhase 4Silverstein Eye CentersNCT03886779Written as Bromfenac
See all 45 studies that test bromfenac →
As the comparator · 1 — what is tested is compared with bromfenac
Codes
What other systems call bromfenac · ClinicalTrials.gg INT003334
- MeSH (NLM) C053083bromfenacConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 864P0921DWBROMFENACConfirmed FDA, NLM, Wikidata
- RxNorm 19737Confirmed FDA, Wikidata
- Wikidata Q2487682bromfenacConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65271BromfenacOne source FDA
- DrugBank DB00963One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C053083 | bromfenac | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 864P0921DW | BROMFENAC | Confirmed FDA, NLM, Wikidata |
| RxNorm | 19737 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2487682 | bromfenac | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65271 | Bromfenac | One source FDA |
| DrugBank | DB00963 | — | One source Wikidata |
Also registered as bromfenac sodium (UNII 8ECV571Y37 · RxNorm 47364).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.